ArticleImmunoTargets and therapy2024

Addition of Immune Checkpoint Inhibitor Showed Better Efficacy for Infiltrative Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy and Lenvatinib: A Multicenter Retrospective Study.

Wei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.